Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.

Larsen JC, Johnson NH.

Mil Med. 2009 Jun;174(6):647-51. Review.

PMID:
19585782
2.

Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.

Galyov EE, Brett PJ, DeShazer D.

Annu Rev Microbiol. 2010;64:495-517. doi: 10.1146/annurev.micro.112408.134030. Review.

PMID:
20528691
3.

Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.

Gilad J.

Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):233-41. Review.

PMID:
18221181
4.

DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.

Memišević V, Kumar K, Zavaljevski N, DeShazer D, Wallqvist A, Reifman J.

BMC Bioinformatics. 2016 Sep 20;17:387. doi: 10.1186/s12859-016-1242-z.

5.

Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.

Lafontaine ER, Zimmerman SM, Shaffer TL, Michel F, Gao X, Hogan RJ.

PLoS One. 2013 Oct 2;8(10):e76804. doi: 10.1371/journal.pone.0076804. eCollection 2013.

6.

Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Zimmerman SM, Dyke JS, Jelesijevic TP, Michel F, Lafontaine ER, Hogan RJ.

Infect Immun. 2017 Jul 19;85(8). pii: e00102-17. doi: 10.1128/IAI.00102-17. Print 2017 Aug.

7.

Molecular identification and typing of Burkholderia pseudomallei and Burkholderia mallei: when is enough enough?

Antonov VA, Tkachenko GA, Altukhova VV, Savchenko SS, Zinchenko OV, Viktorov DV, Zamaraev VS, Ilyukhin VI, Alekseev VV.

Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S134-9. doi: 10.1016/S0035-9203(08)70030-0.

PMID:
19121675
8.

Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.

Tiyawisutsri R, Holden MT, Tumapa S, Rengpipat S, Clarke SR, Foster SJ, Nierman WC, Day NP, Peacock SJ.

BMC Microbiol. 2007 Mar 15;7:19.

9.

Antibiotic resistance in Burkholderia species.

Rhodes KA, Schweizer HP.

Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30. Review.

10.

Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.

Schell MA, Lipscomb L, DeShazer D.

J Bacteriol. 2008 Apr;190(7):2306-13. doi: 10.1128/JB.01735-07. Epub 2008 Jan 25.

11.

Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.

Duval BD, Elrod MG, Gee JE, Chantratita N, Tandhavanant S, Limmathurotsakul D, Hoffmaster AR.

Am J Trop Med Hyg. 2014 Jun;90(6):1043-6. doi: 10.4269/ajtmh.14-0025. Epub 2014 Apr 7.

12.

Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.

Balder R, Lipski S, Lazarus JJ, Grose W, Wooten RM, Hogan RJ, Woods DE, Lafontaine ER.

BMC Microbiol. 2010 Sep 28;10:250. doi: 10.1186/1471-2180-10-250.

13.

Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.

Lipsitz R, Garges S, Aurigemma R, Baccam P, Blaney DD, Cheng AC, Currie BJ, Dance D, Gee JE, Larsen J, Limmathurotsakul D, Morrow MG, Norton R, O'Mara E, Peacock SJ, Pesik N, Rogers LP, Schweizer HP, Steinmetz I, Tan G, Tan P, Wiersinga WJ, Wuthiekanun V, Smith TL.

Emerg Infect Dis. 2012 Dec;18(12):e2. doi: 10.3201/eid1812.120638.

14.

BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei.

Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, Tuanyok A, Wagner DM, Currie BJ, Keim PS.

PLoS One. 2010 Nov 12;5(11):e15413. doi: 10.1371/journal.pone.0015413.

15.
16.

Present and future therapeutic strategies for melioidosis and glanders.

Estes DM, Dow SW, Schweizer HP, Torres AG.

Expert Rev Anti Infect Ther. 2010 Mar;8(3):325-38. doi: 10.1586/eri.10.4.

17.

[Some properties of plasmocoagulase of the causative agents of glanders and melioidosis].

Narbutovich NI, Lomova LV, Ageeva NP, Kucheriaeva VT, Seimova IK.

Zh Mikrobiol Epidemiol Immunobiol. 2005 May-Jun;(3):87-9. Russian.

PMID:
16028525
18.

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.

Bernhards RC, Cote CK, Amemiya K, Waag DM, Klimko CP, Worsham PL, Welkos SL.

Arch Microbiol. 2017 Mar;199(2):277-301. doi: 10.1007/s00203-016-1303-8. Epub 2016 Oct 13.

19.

Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.

Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt BG.

J Clin Microbiol. 2003 May;41(5):2068-79. Erratum in: J Clin Microbiol. 2003 Oct;41(10):4913.

20.

A Quadruplex Real-Time PCR Assay for the Rapid Detection and Differentiation of the Most Relevant Members of the B. pseudomallei Complex: B. mallei, B. pseudomallei, and B. thailandensis.

Lowe CW, Satterfield BA, Nelson DB, Thiriot JD, Heder MJ, March JK, Drake DS, Lew CS, Bunnell AJ, Moore ES, O'Neill KL, Robison RA.

PLoS One. 2016 Oct 13;11(10):e0164006. doi: 10.1371/journal.pone.0164006. eCollection 2016.

Supplemental Content

Support Center